The genotype of early-transmitting HIV gp120s promotes α (4) β(7)-reactivity, revealing α (4) β(7) +/CD4+ T cells as key targets in mucosal transmission.
Mucosal transmission of HIV is inefficient. The virus must breach physical barriers before it infects mucosal CD4+ T cells. Low-level viral replication occurs initially in mucosal CD4+ T cells, but within days high-level replication occurs in Peyer's patches, the gut lamina propria and mesenter...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8784641fb4874ee6932b21860cd590a8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:8784641fb4874ee6932b21860cd590a8 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:8784641fb4874ee6932b21860cd590a82021-11-18T06:03:34ZThe genotype of early-transmitting HIV gp120s promotes α (4) β(7)-reactivity, revealing α (4) β(7) +/CD4+ T cells as key targets in mucosal transmission.1553-73661553-737410.1371/journal.ppat.1001301https://doaj.org/article/8784641fb4874ee6932b21860cd590a82011-02-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21383973/pdf/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374Mucosal transmission of HIV is inefficient. The virus must breach physical barriers before it infects mucosal CD4+ T cells. Low-level viral replication occurs initially in mucosal CD4+ T cells, but within days high-level replication occurs in Peyer's patches, the gut lamina propria and mesenteric lymph nodes. Understanding the early events in HIV transmission may provide valuable information relevant to the development of an HIV vaccine. The viral quasispecies in a donor contracts through a genetic bottleneck in the recipient, such that, in low-risk settings, infection is frequently established by a single founder virus. Early-transmitting viruses in subtypes A and C mucosal transmission tend to encode gp120s with reduced numbers of N-linked glycosylation sites at specific positions throughout the V1-V4 domains, relative to typical chronically replicating isolates in the donor quasispecies. The transmission advantage gained by the absence of these N-linked glycosylation sites is unknown. Using primary α₄β₇/CD4+ T cells and a flow-cytometry based steady-state binding assay we show that the removal of transmission-associated N-linked glycosylation sites results in large increases in the specific reactivity of gp120 for integrin-α₄β₇. High-affinity for integrin α₄β₇, although not found in many gp120s, was observed in early-transmitting gp120s that we analyzed. Increased α₄β₇ affinity is mediated by sequences encoded in gp120 V1/V2. α₄β₇-reactivity was also influenced by N-linked glycosylation sites located in C3/V4. These results suggest that the genetic bottleneck that occurs after transmission may frequently involve a relative requirement for the productive infection of α₄β₇+/CD4+ T cells. Early-transmitting gp120s were further distinguished by their dependence on avidity-effects to interact with CD4, suggesting that these gp120s bear unusual structural features not present in many well-characterized gp120s derived from chronically replicating viruses. Understanding the structural features that characterize early-transmitting gp120s may aid in the design of an effective gp120-based subunit vaccine.Fatima NawazClaudia CicalaDonald Van RykKatharine E BlockKatija JelicicJonathan P McNallyOlajumoke OgundareMassimiliano PascuccioNikita PatelDanlan WeiAnthony S FauciJames ArthosPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 7, Iss 2, p e1001301 (2011) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5 |
spellingShingle |
Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5 Fatima Nawaz Claudia Cicala Donald Van Ryk Katharine E Block Katija Jelicic Jonathan P McNally Olajumoke Ogundare Massimiliano Pascuccio Nikita Patel Danlan Wei Anthony S Fauci James Arthos The genotype of early-transmitting HIV gp120s promotes α (4) β(7)-reactivity, revealing α (4) β(7) +/CD4+ T cells as key targets in mucosal transmission. |
description |
Mucosal transmission of HIV is inefficient. The virus must breach physical barriers before it infects mucosal CD4+ T cells. Low-level viral replication occurs initially in mucosal CD4+ T cells, but within days high-level replication occurs in Peyer's patches, the gut lamina propria and mesenteric lymph nodes. Understanding the early events in HIV transmission may provide valuable information relevant to the development of an HIV vaccine. The viral quasispecies in a donor contracts through a genetic bottleneck in the recipient, such that, in low-risk settings, infection is frequently established by a single founder virus. Early-transmitting viruses in subtypes A and C mucosal transmission tend to encode gp120s with reduced numbers of N-linked glycosylation sites at specific positions throughout the V1-V4 domains, relative to typical chronically replicating isolates in the donor quasispecies. The transmission advantage gained by the absence of these N-linked glycosylation sites is unknown. Using primary α₄β₇/CD4+ T cells and a flow-cytometry based steady-state binding assay we show that the removal of transmission-associated N-linked glycosylation sites results in large increases in the specific reactivity of gp120 for integrin-α₄β₇. High-affinity for integrin α₄β₇, although not found in many gp120s, was observed in early-transmitting gp120s that we analyzed. Increased α₄β₇ affinity is mediated by sequences encoded in gp120 V1/V2. α₄β₇-reactivity was also influenced by N-linked glycosylation sites located in C3/V4. These results suggest that the genetic bottleneck that occurs after transmission may frequently involve a relative requirement for the productive infection of α₄β₇+/CD4+ T cells. Early-transmitting gp120s were further distinguished by their dependence on avidity-effects to interact with CD4, suggesting that these gp120s bear unusual structural features not present in many well-characterized gp120s derived from chronically replicating viruses. Understanding the structural features that characterize early-transmitting gp120s may aid in the design of an effective gp120-based subunit vaccine. |
format |
article |
author |
Fatima Nawaz Claudia Cicala Donald Van Ryk Katharine E Block Katija Jelicic Jonathan P McNally Olajumoke Ogundare Massimiliano Pascuccio Nikita Patel Danlan Wei Anthony S Fauci James Arthos |
author_facet |
Fatima Nawaz Claudia Cicala Donald Van Ryk Katharine E Block Katija Jelicic Jonathan P McNally Olajumoke Ogundare Massimiliano Pascuccio Nikita Patel Danlan Wei Anthony S Fauci James Arthos |
author_sort |
Fatima Nawaz |
title |
The genotype of early-transmitting HIV gp120s promotes α (4) β(7)-reactivity, revealing α (4) β(7) +/CD4+ T cells as key targets in mucosal transmission. |
title_short |
The genotype of early-transmitting HIV gp120s promotes α (4) β(7)-reactivity, revealing α (4) β(7) +/CD4+ T cells as key targets in mucosal transmission. |
title_full |
The genotype of early-transmitting HIV gp120s promotes α (4) β(7)-reactivity, revealing α (4) β(7) +/CD4+ T cells as key targets in mucosal transmission. |
title_fullStr |
The genotype of early-transmitting HIV gp120s promotes α (4) β(7)-reactivity, revealing α (4) β(7) +/CD4+ T cells as key targets in mucosal transmission. |
title_full_unstemmed |
The genotype of early-transmitting HIV gp120s promotes α (4) β(7)-reactivity, revealing α (4) β(7) +/CD4+ T cells as key targets in mucosal transmission. |
title_sort |
genotype of early-transmitting hiv gp120s promotes α (4) β(7)-reactivity, revealing α (4) β(7) +/cd4+ t cells as key targets in mucosal transmission. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2011 |
url |
https://doaj.org/article/8784641fb4874ee6932b21860cd590a8 |
work_keys_str_mv |
AT fatimanawaz thegenotypeofearlytransmittinghivgp120spromotesa4b7reactivityrevealinga4b7cd4tcellsaskeytargetsinmucosaltransmission AT claudiacicala thegenotypeofearlytransmittinghivgp120spromotesa4b7reactivityrevealinga4b7cd4tcellsaskeytargetsinmucosaltransmission AT donaldvanryk thegenotypeofearlytransmittinghivgp120spromotesa4b7reactivityrevealinga4b7cd4tcellsaskeytargetsinmucosaltransmission AT katharineeblock thegenotypeofearlytransmittinghivgp120spromotesa4b7reactivityrevealinga4b7cd4tcellsaskeytargetsinmucosaltransmission AT katijajelicic thegenotypeofearlytransmittinghivgp120spromotesa4b7reactivityrevealinga4b7cd4tcellsaskeytargetsinmucosaltransmission AT jonathanpmcnally thegenotypeofearlytransmittinghivgp120spromotesa4b7reactivityrevealinga4b7cd4tcellsaskeytargetsinmucosaltransmission AT olajumokeogundare thegenotypeofearlytransmittinghivgp120spromotesa4b7reactivityrevealinga4b7cd4tcellsaskeytargetsinmucosaltransmission AT massimilianopascuccio thegenotypeofearlytransmittinghivgp120spromotesa4b7reactivityrevealinga4b7cd4tcellsaskeytargetsinmucosaltransmission AT nikitapatel thegenotypeofearlytransmittinghivgp120spromotesa4b7reactivityrevealinga4b7cd4tcellsaskeytargetsinmucosaltransmission AT danlanwei thegenotypeofearlytransmittinghivgp120spromotesa4b7reactivityrevealinga4b7cd4tcellsaskeytargetsinmucosaltransmission AT anthonysfauci thegenotypeofearlytransmittinghivgp120spromotesa4b7reactivityrevealinga4b7cd4tcellsaskeytargetsinmucosaltransmission AT jamesarthos thegenotypeofearlytransmittinghivgp120spromotesa4b7reactivityrevealinga4b7cd4tcellsaskeytargetsinmucosaltransmission AT fatimanawaz genotypeofearlytransmittinghivgp120spromotesa4b7reactivityrevealinga4b7cd4tcellsaskeytargetsinmucosaltransmission AT claudiacicala genotypeofearlytransmittinghivgp120spromotesa4b7reactivityrevealinga4b7cd4tcellsaskeytargetsinmucosaltransmission AT donaldvanryk genotypeofearlytransmittinghivgp120spromotesa4b7reactivityrevealinga4b7cd4tcellsaskeytargetsinmucosaltransmission AT katharineeblock genotypeofearlytransmittinghivgp120spromotesa4b7reactivityrevealinga4b7cd4tcellsaskeytargetsinmucosaltransmission AT katijajelicic genotypeofearlytransmittinghivgp120spromotesa4b7reactivityrevealinga4b7cd4tcellsaskeytargetsinmucosaltransmission AT jonathanpmcnally genotypeofearlytransmittinghivgp120spromotesa4b7reactivityrevealinga4b7cd4tcellsaskeytargetsinmucosaltransmission AT olajumokeogundare genotypeofearlytransmittinghivgp120spromotesa4b7reactivityrevealinga4b7cd4tcellsaskeytargetsinmucosaltransmission AT massimilianopascuccio genotypeofearlytransmittinghivgp120spromotesa4b7reactivityrevealinga4b7cd4tcellsaskeytargetsinmucosaltransmission AT nikitapatel genotypeofearlytransmittinghivgp120spromotesa4b7reactivityrevealinga4b7cd4tcellsaskeytargetsinmucosaltransmission AT danlanwei genotypeofearlytransmittinghivgp120spromotesa4b7reactivityrevealinga4b7cd4tcellsaskeytargetsinmucosaltransmission AT anthonysfauci genotypeofearlytransmittinghivgp120spromotesa4b7reactivityrevealinga4b7cd4tcellsaskeytargetsinmucosaltransmission AT jamesarthos genotypeofearlytransmittinghivgp120spromotesa4b7reactivityrevealinga4b7cd4tcellsaskeytargetsinmucosaltransmission |
_version_ |
1718424678643531776 |